These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 23778152

  • 1. Cost-effectiveness of an advance notification letter to increase colorectal cancer screening.
    Cronin P, Goodall S, Lockett T, O'Keefe CM, Norman R, Church J.
    Int J Technol Assess Health Care; 2013 Jul; 29(3):261-8. PubMed ID: 23778152
    [Abstract] [Full Text] [Related]

  • 2. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T, Ladabaum U, Alperin P, Caldwell C, Smith R, Levin TR.
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cost-effectiveness simulation and analysis of colorectal cancer screening in Hong Kong Chinese population: comparison amongst colonoscopy, guaiac and immunologic fecal occult blood testing.
    Wong CK, Lam CL, Wan YF, Fong DY.
    BMC Cancer; 2015 Oct 15; 15():705. PubMed ID: 26471036
    [Abstract] [Full Text] [Related]

  • 7. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK, Ng SS, Leung MC, Sung JJ.
    Aliment Pharmacol Ther; 2008 Aug 01; 28(3):353-63. PubMed ID: 18638075
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cost-effectiveness modeling of colorectal cancer: computed tomography colonography vs colonoscopy or fecal occult blood tests.
    Lucidarme O, Cadi M, Berger G, Taieb J, Poynard T, Grenier P, Beresniak A.
    Eur J Radiol; 2012 Jul 01; 81(7):1413-9. PubMed ID: 21444171
    [Abstract] [Full Text] [Related]

  • 11. Cost-effectiveness analysis of colorectal cancer screening with stool DNA testing in intermediate-incidence countries.
    Wu GH, Wang YM, Yen AM, Wong JM, Lai HC, Warwick J, Chen TH.
    BMC Cancer; 2006 May 24; 6():136. PubMed ID: 16723013
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
    Manser R, Dalton A, Carter R, Byrnes G, Elwood M, Campbell DA.
    Lung Cancer; 2005 May 24; 48(2):171-85. PubMed ID: 15829317
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Incremental cost-effectiveness of the pre- and post-bevacizumab eras of metastatic colorectal cancer therapy in British Columbia, Canada.
    Hedden L, Kennecke H, Villa D, Johnston K, Speers C, Kovacic L, Renouf DJ, Peacock S.
    Eur J Cancer; 2012 Sep 24; 48(13):1969-76. PubMed ID: 22325838
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Endoscopist-directed propofol administration versus anesthesiologist assistance for colorectal cancer screening: a cost-effectiveness analysis.
    Hassan C, Rex DK, Cooper GS, Benamouzig R.
    Endoscopy; 2012 May 24; 44(5):456-64. PubMed ID: 22531982
    [Abstract] [Full Text] [Related]

  • 20. Health benefits and costs of screening for colorectal cancer in people on dialysis or who have received a kidney transplant.
    Wong G, Li MW, Howard K, Hua DK, Chapman JR, Bourke M, Turner R, Tong A, Craig JC.
    Nephrol Dial Transplant; 2013 Apr 24; 28(4):917-26. PubMed ID: 23182812
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.